Corcept Therapeutics (United States)

Corcept Therapeutics (United States)

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Corcept Therapeutics (United States), United States, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

60%


Total
Publications

149


Total Open
Publications

90


Total
Citations

4.8K


Open Access
Percentage

60%


Total
Publications

149


Total Open
Publications

90


Total
Citations

4.8K

Wikipedia

Website

download

Breakdown

12% 41% 7% 40%

Publisher Open

12%

Both

41%

Other Platform Open

7%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

48%OA Journal

OA Journal 48%

37

Hybrid 30%

23

No Guarantees 22%

17

Other Platform Open

Domain 73%

52

Institution 28%

20

Other Internet 20%

14

Preprint 3%

2

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
52
DOI
Other Internet
14
Royal Netherlands Academy of Arts and Sciences
Institution
12
universiteitleiden.nl OAI-PMH Repository
Institution
7
uj.edu.pl OAI-PMH Repository
Institution
3
University of Turin
Institution
2
uniroma1.it OAI-PMH Repository
Institution
2
King's College London
Institution
2
iu.edu OAI-PMH Repository
Institution
2
Europe PMC
Domain
2
1 / 2

Data updated 18 August 2025

Share

Share

Share